Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fimasartan (BR-A-657) is a non-peptide angiotensin II receptor antagonist (ARB) used for the treatment of hypertension and heart failure. Concurrent administration of fimasartan with diuretic hydrochlorothiazide has shown to be safe in clinical trials.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 47.00 | |
10 mg | In stock | $ 72.00 | |
25 mg | In stock | $ 108.00 | |
50 mg | In stock | $ 128.00 | |
100 mg | In stock | $ 198.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 52.00 |
Description | Fimasartan (BR-A-657) is a non-peptide angiotensin II receptor antagonist (ARB) used for the treatment of hypertension and heart failure. Concurrent administration of fimasartan with diuretic hydrochlorothiazide has shown to be safe in clinical trials. |
Synonyms | BR-A-657, Kanarb |
Molecular Weight | 501.65 |
Formula | C27H31N7OS |
CAS No. | 247257-48-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 49 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fimasartan 247257-48-3 Apoptosis Endocrinology/Hormones RAAS BR-A 657 Angiotensin Receptor BR-A657 BR-A-657 Inhibitor Kanarb inhibit inhibitor